Morning Briefing
Summaries of health policy coverage from major news organizations
Government Has Known For Years Mylan Was Overcharging Medicaid For EpiPens
The internal watchdog at the U.S. Department of Health and Human Services warned the office tasked with administering federal health insurance programs that Mylan NV's EpiPen was improperly classified as a generic drug in 2009, Senator Charles Grassley said on Tuesday. (Lynch, 11/8)
Grassley, an Iowa Republican, asked the Department of Health and Human Services inspector general to hand over records related to its notification seven years ago that the Center for Medicare and Medicaid Services was overpaying for the allergy shot. “It appears the EpiPen was misclassified for years, and CMS was notified of the problem,” Grassley said in a statement Tuesday. “If no one did anything about the misclassification, why not? This could mean hundreds of millions of dollars in taxpayer over-payments occurred without justification.” (Edney, 11/8)
